Chemoinformaics analysis of Urtica-Rhamnogalacturan-RP-3
| Molecular Weight | 462.407 | nRot | 5 |
| Heavy Atom Molecular Weight | 440.231 | nRig | 24 |
| Exact Molecular Weight | 462.116 | nRing | 4 |
| Solubility: LogS | -3.901 | nHRing | 2 |
| Solubility: LogP | 0.808 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 60.2314 |
| nHD | 6 | BPOL | 29.8826 |
| QED | 0.302 |
| Synth | 3.836 |
| Natural Product Likeliness | 1.912 |
| NR-PPAR-gamma | 0.927 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.793 |
| HIA | 0.623 |
| CACO-2 | -5.959 |
| MDCK | 0.000022 |
| BBB | 0.123 |
| PPB | 0.834643 |
| VDSS | 1.003 |
| FU | 0.127295 |
| CYP1A2-inh | 0.058 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.728 |
| CYP2d6-inh | 0.073 |
| CYP2d6-sub | 0.257 |
| CYP3a4-inh | 0.05 |
| CYP3a4-sub | 0.035 |
| CL | 3.626 |
| T12 | 0.544 |
| hERG | 0.017 |
| Ames | 0.76 |
| ROA | 0.049 |
| SkinSen | 0.039 |
| Carcinogencity | 0.117 |
| EI | 0.013 |
| Respiratory | 0.022 |
| NR-Aromatase | 0.928 |
| Antiviral | Yes |
| Prediction | 0.924918 |